294 related articles for article (PubMed ID: 29143220)
1. Validation of the 8th AJCC prognostic staging system for breast cancer in a population-based setting.
Abdel-Rahman O
Breast Cancer Res Treat; 2018 Feb; 168(1):269-275. PubMed ID: 29143220
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the external validity of the American Joint Committee on Cancer 8th staging system for anal carcinoma.
Oweira H; Giryes A; Mannhart M; Decker M; Schlumpf R; Abdel-Rahman O
Curr Med Res Opin; 2018 May; 34(5):923-929. PubMed ID: 29448859
[TBL] [Abstract][Full Text] [Related]
3. Modified staging system for pulmonary carcinoids on the basis of lung cancer TNM system.
Abdel-Rahman O
Clin Transl Oncol; 2018 May; 20(5):670-677. PubMed ID: 29022170
[TBL] [Abstract][Full Text] [Related]
4. Validation of the AJCC 8th lung cancer staging system among patients with small cell lung cancer.
Abdel-Rahman O
Clin Transl Oncol; 2018 Apr; 20(4):550-556. PubMed ID: 28808860
[TBL] [Abstract][Full Text] [Related]
5. Validation of the 8th AJCC staging system for gastric cancer in a population-based setting.
Abdel-Rahman O
Expert Rev Gastroenterol Hepatol; 2018 May; 12(5):525-530. PubMed ID: 29198151
[TBL] [Abstract][Full Text] [Related]
6. Challenging a dogma; AJCC 8th staging system is not sufficient to predict outcomes of patients with malignant pleural mesothelioma.
Abdel-Rahman O
Lung Cancer; 2017 Nov; 113():128-133. PubMed ID: 29110839
[TBL] [Abstract][Full Text] [Related]
7. Revisiting Dukes' paradigm; some node positive colon cancer patients have better prognosis than some node negative patients.
Abdel-Rahman O
Clin Transl Oncol; 2018 Jun; 20(6):794-800. PubMed ID: 29086248
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the prognostic and discriminating value of the novel bioscore system for breast cancer; a SEER database analysis.
Abdel-Rahman O
Breast Cancer Res Treat; 2017 Jul; 164(1):231-236. PubMed ID: 28417332
[TBL] [Abstract][Full Text] [Related]
9. Validation of the AJCC 8th prognostic system for breast cancer in an Asian healthcare setting.
Wong RX; Wong FY; Lim J; Lian WX; Yap YS
Breast; 2018 Aug; 40():38-44. PubMed ID: 29677569
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the prognostic value of the 8th AJCC staging system for patients with clinically staged prostate cancer; A time to sub-classify stage IV?
Abdel-Rahman O
PLoS One; 2017; 12(11):e0188450. PubMed ID: 29182656
[TBL] [Abstract][Full Text] [Related]
11. Validation of the prognostic value of new sub-stages within the AJCC 8th edition of non-small cell lung cancer.
Abdel-Rahman O
Clin Transl Oncol; 2017 Nov; 19(11):1414-1420. PubMed ID: 28497423
[TBL] [Abstract][Full Text] [Related]
12. Validation of the Eighth AJCC New Substages for Bladder Cancer Among Different Staging Contexts.
Abdel-Rahman O
Clin Genitourin Cancer; 2017 Dec; 15(6):e1095-e1106. PubMed ID: 28843376
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the 8th AJCC staging system for pathologically versus clinically staged pancreatic adenocarcinoma: A time to revisit a dogma?
Abdel-Rahman O
Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):64-69. PubMed ID: 29428107
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the prognostic stage in the 8th edition of the American Joint Committee on Cancer in locally advanced breast cancer: An analysis based on SEER 18 database.
Wang M; Chen H; Wu K; Ding A; Zhang M; Zhang P
Breast; 2018 Feb; 37():56-63. PubMed ID: 29100045
[TBL] [Abstract][Full Text] [Related]
15. Revisiting the Prognostic Heterogeneity of AJCC Stage IV Carcinomas of the Upper Urinary Tract.
Abdel-Rahman O
Clin Genitourin Cancer; 2018 Aug; 16(4):e859-e865. PubMed ID: 29534942
[TBL] [Abstract][Full Text] [Related]
16. Validation of the Prognostic Significance of the Prognostic Stage Group According to the Eighth Edition of American Cancer Joint Committee on Cancer Staging System in Triple-Negative Breast Cancer: An Analysis From Surveillance, Epidemiology, and End Results 18 Database.
Luo SP; Wu QS; Chen H; Wang XX; Chen QX; Zhang J; Song CG
J Surg Res; 2020 Mar; 247():211-219. PubMed ID: 31706539
[TBL] [Abstract][Full Text] [Related]
17. AJCC 8th edition prognostic staging provides no better discriminatory ability in prognosis than anatomical staging in triple negative breast cancer.
He J; Tsang JY; Xu X; Li J; Li M; Chao X; Xu Y; Luo R; Tse GM; Sun P
BMC Cancer; 2020 Jan; 20(1):18. PubMed ID: 31906874
[TBL] [Abstract][Full Text] [Related]
18. Modified lymph node ratio improves the prognostic predictive ability for breast cancer patients compared with other lymph node staging systems.
Jin ML; Gong Y; Pei YC; Ji P; Hu X; Shao ZM
Breast; 2020 Feb; 49():93-100. PubMed ID: 31783315
[TBL] [Abstract][Full Text] [Related]
19. Survival analysis for male ductal and lobular breast cancer patients with different stages.
Wang J; Sun Y; Qu J; Zuo H; Zhao X; Liu L; Feng J; Wang J; Zhang G
Future Oncol; 2019 Jan; 15(2):167-180. PubMed ID: 30088776
[TBL] [Abstract][Full Text] [Related]
20. The combined pN stage and breast cancer subtypes in breast cancer: a better discriminator of outcome can be used to refine the 8th AJCC staging manual.
Yang ZJ; Yu Y; Chi JR; Guan M; Zhao Y; Cao XC
Breast Cancer; 2018 May; 25(3):315-324. PubMed ID: 29353447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]